Aspirin in small doses - a good prophylactic agent of malignant tumors, researchers believe.
However, there is a perception that the prophylactic use of aspirin can cause bleeding. This risk is dose-dependent, which takes people. In this regard, scientists have wondered whether aspirin in small amounts to prophylactic anti-cancer effect, without threatening hemorrhage and blood loss. The research results were very encouraging.
The article, published in Nature Reviews Clinical Oncology, researchers say that 75-100 mg of aspirin a day is enough to reduce the risk of cancer. During the first 3-5 years after the use of aspirin, the number of newly diagnosed cancer cases dropped by 20% in five years or more - 30%, experts have found. Accordingly, the decreased mortality from cancer. This means that aspirin improved the prognosis for those patients whose tumors have been. In an attempt to increase the dose of aspirin is no statistical significant improvement has not occurred.
The authors emphasize the finding that did not make distinctions between types of cancer, that is, with some caution we can talk about the general anti-cancer effect of small doses of medication. On the other hand, it is possible that some types of cancer can be quite resistant to aspirin, while others, conversely, is particularly sensitive. So now to be systematic and thorough work on figuring out exactly how aspirin interacts with cancer, and if you can get in the way of it a tangible clinical benefit.
According to researchers from the American Cancer Society, for the prevention of cancer is enough to use every bit of aspirin.
Note that aspirin is used not only against colds and as an antipyretic and analgesic general purpose, but it is often prescribed for the prevention of cardiovascular disease. In addition, previously discussed on its anticancer properties: there is evidence that it reduces the risk of colon cancer and benign tumors in the prostate gland.
Note that aspirin is used not only against colds and as an antipyretic and analgesic general purpose, but it is often prescribed for the prevention of cardiovascular disease. In addition, previously discussed on its anticancer properties: there is evidence that it reduces the risk of colon cancer and benign tumors in the prostate gland.
However, there is a perception that the prophylactic use of aspirin can cause bleeding. This risk is dose-dependent, which takes people. In this regard, scientists have wondered whether aspirin in small amounts to prophylactic anti-cancer effect, without threatening hemorrhage and blood loss. The research results were very encouraging.
The article, published in Nature Reviews Clinical Oncology, researchers say that 75-100 mg of aspirin a day is enough to reduce the risk of cancer. During the first 3-5 years after the use of aspirin, the number of newly diagnosed cancer cases dropped by 20% in five years or more - 30%, experts have found. Accordingly, the decreased mortality from cancer. This means that aspirin improved the prognosis for those patients whose tumors have been. In an attempt to increase the dose of aspirin is no statistical significant improvement has not occurred.
 |
| Low doses of aspirin protect against cancer |
source:heaalthy.blogspot.com
.png "English"){kind=small}
0 comments:
Post a Comment